Know Labs, Inc. (KNW)

NYSEAMERICAN: KNW · IEX Real-Time Price · USD
0.630
-0.008 (-1.25%)
At close: Mar 28, 2024, 4:00 PM
0.620
-0.010 (-1.59%)
After-hours: Mar 28, 2024, 4:24 PM EDT

Company Description

Know Labs, Inc., together with its subsidiaries, focuses on the development and commercialization of proprietary sensor technology by radio and microwave spectroscopy in the United States.

The company's proprietary platform technologies include ChromaID and Bio-RFID technologies that utilizes electromagnetic energy to detect, record, identify, and measure the signature of said materials or analytes.

The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018.

Know Labs, Inc. was incorporated in 1998 and is based in Seattle, Washington.

Know Labs, Inc.
Know Labs logo
Country United States
Founded 1998
Industry Scientific & Technical Instruments
Sector Technology
Employees 12
CEO Ronald P. Erickson J.D.

Contact Details

Address:
500 Union Street, Suite 810
Seattle, Washington 98101
United States
Phone 206-903-1351
Website knowlabs.co

Stock Details

Ticker Symbol KNW
Exchange NYSEAMERICAN
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001074828
ISIN Number US4992381032
Employer ID 90-0273142
SIC Code 3829

Key Executives

Name Position
Ronald P. Erickson J.D. Founder, Chief Executive Officer, Treasurer and Chairman
Peter Joseph Conley Chief Financial Officer and Senior Vice President of Intellectual Property
Jessica English Chief Marketing Officer
Dr. James H. Anderson Jr., M.D. Chief Medical Officer and Chairman of Medical, Scientific and Regulatory Advisory Board
Steven T. Kent Chief Product Officer
Leonardo Trautwein Chief Commercial Officer
Jordyn Hujar Chief of Staff

Latest SEC Filings

Date Type Title
Mar 20, 2024 424B5 Filing
Mar 20, 2024 8-K Current Report
Mar 6, 2024 8-K/A [Amend] Current report
Mar 6, 2024 8-K Current Report
Feb 29, 2024 8-K Current Report
Feb 27, 2024 8-K Current Report
Feb 14, 2024 10-Q Quarterly Report
Feb 14, 2024 8-K Current Report
Jan 11, 2024 EFFECT Notice of Effectiveness
Jan 5, 2024 S-3/A [Amend] Registration statement under Securities Act of 1933